All Information (Except Text) for S.3077 - MEDS Act114th Congress (2015-2016)
|Sponsor:||Sen. Schatz, Brian [D-HI] (Introduced 06/20/2016)|
|Committees:||Senate - Judiciary|
|Latest Action:||Senate - 06/20/2016 Read twice and referred to the Committee on the Judiciary. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
There is 1 version of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Actions Overview (1)
|06/20/2016||Introduced in Senate|
06/20/2016 Introduced in Senate
All Actions (1)
|06/20/2016||Read twice and referred to the Committee on the Judiciary.|
Action By: Senate
06/20/2016 Read twice and referred to the Committee on the Judiciary.
|Sen. Hatch, Orrin G. [R-UT]*||06/20/2016|
|Sen. Tillis, Thom [R-NC]*||06/20/2016|
|Sen. Coons, Christopher A. [D-DE]*||06/20/2016|
|Committee / Subcommittee||Date||Activity||Reports|
|Senate Judiciary||06/20/2016||Referred to|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
Latest Summary (1)
Introduced in Senate (06/20/2016)
Marijuana Effective Drug Studies Act of 2016 or the MEDS Act
This bill amends the Controlled Substances Act to:
- establish, with respect to marijuana research, a new federal registration process that is separate from the process for research involving other schedule I drugs;
- establish a process for registering persons to manufacture or distribute marijuana for purposes of either research or the commercial production of certain approved drugs containing or derived from marijuana; and
- modify other requirements related to marijuana research and production.